MAPT and early-onset autosomal dominant Alzheimer disease: Specifically, for the constant independent change of the biomarkers over time part of the model c→, an increase for amyloid positron emission tomography (PET) and CSF tau as well as a decrease for Alzheimer’s disease cognitive assessment (ADAS-cog) and hippocampal volume over time were estimated from empirical data.